Search Within

Sridevi Rajeeve

Formats
  1. Meeting Abstract (26)
  2. Journal Article (5)
  3. Review (2)
  4. Correspondence (1)
Groups
  1. Center for Hematologic Malignancies (28)
  2. Department of Medicine (28)
  3. Hematologic Malignancies, Division of (28)
  4. Myeloma (28)
  5. Bone Marrow Transplant (26)
  6. CTCR Scholars (26)

More Groups

People
  1. Sham Mailankody (28)
  2. Saad Usmani (27)
  3. Alexander Lesokhin (26)
  4. Carlyn Rose Tan (26)
  5. David Chung (26)
  6. Heather Landau (26)

More People

Years
  1. 2025 (2)
  2. 2024 (26)
  3. 2023 (6)
Publications
  1. Blood (14)
  2. Clinical Lymphoma, Myeloma and Leukemia (11)
  3. Blood Advances (2)
  4. Journal of Clinical Oncology (2)
  5. American Journal of Hematology (1)
  6. Blood Cancer Journal (1)

More Publications

Publishers
  1. American Society of Hematology (16)
  2. Elsevier Inc. (11)
  3. American Society of Clinical Oncology (2)
  4. Frontiers Media S.A. (1)
  5. John Wiley & Sons (1)
  6. Nature Publishing Group (1)

More Publishers

Results (34)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Accelerating accessibility of CAR-T/NK therapies – Are AlloCARs and rapid manufacturing platforms the road ahead in improving access in multiple myeloma?
    Review

    Rajeeve, S.; Hoskote, A.; Mailankody, S.
    Seminars in Hematology (2024)

    Fulltext@MSK | Save
  • Real-world schedule de-escalation of teclistamab in patients with relapsed/refractory multiple myeloma
    Meeting Abstract

    Tan, C. R. C.; Derkach, A.; Maclachlan, K.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Rajeeve, S.; Shah, G. L.; Scordo, M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Clinical outcomes of retreatment with daratumumab-based regimens in anti-CD38 refractory multiple myeloma
    Meeting Abstract

    Tan, C. R. C.; Rueda, C.; Shekarkhand, T.; Derkach, A.; Korde, N.; Maclachlan, K.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Unscheduled health care interactions in patients with multiple myeloma receiving T-cell redirection therapies
    Journal Article

    Howard, A. J.; Concepcion, I.; Wang, A. X.; Hamadeh, I. S.; Hultcrantz, M.; Mailankody, S.; Tan, C.; Korde, N.; Lesokhin, A. M.; Hassoun, H.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Antigen escape as a shared mechanism of resistance to BCMA-directed therapies in multiple myeloma
    Journal Article

    Firestone, R. S.; Socci, N. D.; Shekarkhand, T.; Zhu, M.; Qin, W. G.; Hultcrantz, M.; Mailankody, S.; Tan, C. R.; Korde, N.; Lesokhin, A. M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Patterns of CRS with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy
    Journal Article

    Hamadeh, I. S.; Shekarkhand, T.; Rueda, C.; Firestone, R. S.; Wang, A. X.; Korde, N.; Hultcrantz, M. L.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myeloma
    Journal Article

    Costa, B. A.; Flynn, J.; Nishimura, N.; Devlin, S. M.; Farzana, T.; Rajeeve, S.; Chung, D. J.; Landau, H. J.; Lahoud, O. B.; Scordo, M.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • Beyond BCMA: The next wave of CAR T cell therapy in multiple myeloma
    Review

    Miller, K.; Hashmi, H.; Rajeeve, S.
    Frontiers in Oncology (2024)

    Fulltext@MSK | Save
  • Bendamustine bridging versus standard of care chemotherapy on toxicity profile for multiple myeloma patients undergoing CAR T cell therapy
    Meeting Abstract

    Leyfman, Y.; Rajeeve, S.; Sheng, T.; Diniz, M.; Richard, S.; Jagannath, S.; Rossi, A. C.
    Blood (2023)

    Fulltext@MSK | Save
  • Daratumumab, bortezomib, lenalidomide, and dexamethasone (DVRd) and daratumumab, carfilzomib, lenalidomide and dexamethasone (DKRd) as induction therapy in newly diagnosed multiple myeloma
    Meeting Abstract

    Tan, C.; Maclachlan, K. H.; Nemirovsky, D.; Derkach, A.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Rajeeve, S.; Patel, D.; more...
    Blood (2023)

    Fulltext@MSK | Save